The ,-lactamase inhibitors clavulanic acid and sulbactam were combined with mecillinam. ,-Lactamase-containing Escherichia coli resistant to mecillinam was synergistically inhibited by both clavulanic acid and sulbactam. 3-Lactamasecontaining Enterobacter was synergistically inhibited, but strains lacking 1-lactamases were not synergistically inhibited. Synergistic inhibition was noted for 3-lactamase-containing, mecillinam-resistant Klebsiella, Citrobacter, Serratia, and Salmonella isolates, but only 18% of ,B-lactamase-containing Proteus mirabiius, Providencia rettgeri, Providencia stuartii, and Morganella morganii were synergistically inhibited by the combinations.
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Mecillinam is an amidino penicillin which inhibits a large number of gram-negative bacilli resistant to ampicillin, even though it is hydrolyzed by many of the common plasmid and chromosomal 13-lactamases (5, 8) . In earlier studies, we had shown that mecillinam resistance in some organisms could be correlated with production of 3-lactamases. For bined with a high affinity for penicillin-binding protein 2, has been suggested as the reason for the activity of mecillinam against E. coli, Klebsiella, and other Enterobacteriaceae resistant to ampicillin. Clavulanic acid and sulbactam both inhibit ,3-lactamases, primarily the plasmid enzymes and also the broad-spectrum Klebsiella enzyme (2) (3) (4) 6 ). These studies demonstrate that these two 13-lactamase inhibitors cause the majority of E. coli, Klebsiella, Citrobacter, Salmonella, and Serratia resistant to mecillinam to be inhibited by concentrations which could be achieved clinically. In contrast, neither 1-lactamase inhibitor significantly increases the activity of mechllinam against Proteus mirabilis, Providencia, or Acinetobacter. Furthermore, neither clavulanic acid nor sulbactam increase the activity of meciflinam against a significant number of mecillinam-susceptible isolates. In general, clavulanic acid on a micrograms-per-milliliter basis was more effective at increasing the activity of mecillinam than was sulbactam.
These observations suggest that the combinstion of mecillinam with a 1-lactamase inhibitor will extend the activity of this compound to inhibit many resistant isolates. Whether these in vitro observations can be utilized in human infections will be resolved only by further animal and human studies.
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